US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 4.7600
  • -0.0200-0.42%
Close May 10 16:00 ET
  • 4.7000
  • -0.0600-1.26%
Post 18:48 ET
11.00MMarket Cap-367P/E (TTM)

About Moleculin Biotech Company

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.

Company Profile

SymbolMBRX
Company NameMoleculin Biotech
Listing DateJun 2, 2016
Issue Price6.00
Founded2015
CEOMr. Walter V. Klemp
MarketNASDAQ
Employees18
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5300 Memorial Drive,Suite 950
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77007
Phone1-713-300-5160
Websitehttp://www.moleculin.com

Company Executives

  • Name
  • Position
  • Salary
  • Walter V. Klemp
  • Chairman of the Board and Chief Executive Officer
  • 1.97M
  • Jonathan P. Foster
  • Chief Financial Officer, Executive Vice President and Principal Accounting Officer
  • 1.09M
  • Dr. Donald H. Picker, PhD
  • Chief Scientific Officer
  • 699.47K
  • Elizabeth A. Cermak
  • Independent Director
  • 103.44K
  • Robert E. George
  • Independent Director
  • 114.69K
  • John M. Climaco
  • Lead Independent Director
  • 118.44K
  • Dr. Joy Yan, M.D.,PhD
  • Independent Director
  • 88.45K
  • Michael D. Cannon
  • Independent Director
  • 108.44K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg